Optimal timing of chemotherapy and cystectomy

por Karam, Jose A, Kamat, Ashish M
Publicado 2010

A Causal Framework for Making Individualized Treatment Decisions in Oncology

por Msaouel, Pavlos, Lee, Juhee, Karam, Jose A., Thall, Peter F.
Publicado 2022

Surgical Complications of Presurgical Systemic Therapy for Renal Cell Carcinoma: A Systematic Review

por McCormick, Barrett, Meissner, Matthew A., Karam, Jose A., Wood, Christopher G.
Publicado 2017

Clinical and Pathological Complete Remission in a Patient With Metastatic Renal Cell Carcinoma (mRCC) Treated With Sunitinib: Is mRCC Curable With Targeted Therapy?

por Shah, Amishi Y., Karam, Jose A., Lim, Zita D., Ng, Chaan S., Tannir, Nizar M.
Publicado 2015

Cytoreductive surgery in the era of targeted molecular therapy

por Thomas, Arun Z., Adibi, Mehrad, Borregales, Leonardo D., Karam, Jose A., Wood, Christopher G.
Publicado 2015

The current role of cytoreductive nephrectomy for metastatic renal cell carcinoma

por Umbreit, Eric C., McIntosh, Andrew G., Suk-Ouichai, Chalairat, Karam, Jose A., Wood, Christopher G.
Publicado 2021

Role of lymph node dissection at the time of open or minimally invasive nephroureterectomy

por McIntosh, Andrew G., Umbreit, Eric C., Wood, Christopher G., Matin, Surena F., Karam, Jose A.
Publicado 2021

A generative adversarial approach to facilitate archival-quality histopathologic diagnoses from frozen tissue sections

por Falahkheirkhah, Kianoush, Guo, Tao, Hwang, Michael, Tamboli, Pheroze, Wood, Christopher G, Karam, Jose A, Sircar, Kanishka, Bhargava, Rohit
Publicado 2022

Prolyl Hydroxylase 3 Knockdown Accelerates VHL-Mutant Kidney Cancer Growth In Vivo

por Zacharias, Niki M., Wang, Lei, Maity, Tapati, Li, Li, Millward, Steven W., Karam, Jose A., Wood, Christopher G., Navai, Neema
Publicado 2021

Sarcomatoid renal cell carcinoma: biology, natural history and management

por Blum, Kyle A., Gupta, Sounak, Tickoo, Satish K., Chan, Timothy A., Russo, Paul, Motzer, Robert J., Karam, Jose A., Hakimi, A. Ari
Publicado 2020

Unique protein expression signatures of survival time in kidney renal clear cell carcinoma through a pan-cancer screening

por Han, Guangchun, Zhao, Wei, Song, Xiaofeng, Kwok-Shing Ng, Patrick, Karam, Jose A., Jonasch, Eric, Mills, Gordon B., Zhao, Zhongming, Ding, Zhiyong, Jia, Peilin
Publicado 2017

Outcomes of Radiofrequency Ablation for Solitary T1a Renal Cell Carcinoma: A 20-Year Tertiary Cancer Center Experience

por Abdelsalam, Mohamed E., Awad, Ahmed, Baiomy, Ali, Irwin, David, Karam, Jose A., Matin, Surena F., Sheth, Rahul A., Habibollahi, Peiman, Odisio, Bruno C., Lu, Thomas, Ahrar, Kamran
Publicado 2023

Effectiveness of Thermal Ablation for Renal Cell Carcinoma after Prior Partial Nephrectomy

por Abdelsalam, Mohamed E., Hudspeth, Tessa N., Leonards, Laura, Kusin, Samuel B., Buckley, Jennifer R., Bassett, Roland, Awad, Ahmed, Karam, Jose A., Matin, Surena F., Lu, Thomas, Ahrar, Kamran
Publicado 2023

Prospective evaluation of plasma levels of ANGPT2, TuM2PK, and VEGF in patients with renal cell carcinoma

por Gayed, Bishoy A, Gillen, Jessica, Christie, Alana, Peña-Llopis, Samuel, Xie, Xian-Jin, Yan, Jingsheng, Karam, Jose A, Raj, Ganesh, Sagalowsky, Arthur I, Lotan, Yair, Margulis, Vitaly, Brugarolas, James
Publicado 2015

Uc.416 + A promotes epithelial-to-mesenchymal transition through miR-153 in renal cell carcinoma

por Sekino, Yohei, Sakamoto, Naoya, Goto, Keisuke, Honma, Ririno, Shigematsu, Yoshinori, Quoc, Thang Pham, Sentani, Kazuhiro, Oue, Naohide, Teishima, Jun, Kawakami, Fumi, Karam, Jose A, Sircar, Kanishka, Matsubara, Akio, Yasui, Wataru
Publicado 2018

Prognostic role of expression of N-cadherin in patients with upper tract urothelial carcinoma: a multi-institutional study

por Abufaraj, Mohammad, Moschini, Marco, Soria, Francesco, Gust, Kilian, Özsoy, Mehmet, Mathieu, Romain, Rouprêt, Morgan, Margulis, Vitaly, Karam, Jose A., Wood, Christopher G., Briganti, Alberto, Bensalah, Karim, Haitel, Andrea, Shariat, Shahrokh F.
Publicado 2016

Stereotactic Body Radiation Therapy for the Definitive Treatment of Early Stage Kidney Cancer: A Survival Comparison With Surgery, Tumor Ablation, and Observation

por Grant, Stephen R., Lei, Xiudong, Hess, Kenneth R., Smith, Grace L., Matin, Surena F., Wood, Christopher G., Nguyen, Quynh, Frank, Steven J., Anscher, Mitchell S., Smith, Benjamin D., Karam, Jose A., Tang, Chad
Publicado 2020

Very Late Recurrence in Germ Cell Tumor of the Testis: Lessons and Implications

por Moore, Joseph A., Slack, Rebecca S., Lehner, Michael J., Campbell, Matthew T., Shah, Amishi Y., Zhang, Miao, Guo, Charles C., Ward, John F., Karam, Jose A., Wood, Christopher G., Pisters, Louis L., Tu, Shi-Ming
Publicado 2022

Cytoreductive Nephrectomy Following Immune Checkpoint Inhibitor Therapy Is Safe and Facilitates Treatment-free Intervals

por Shapiro, Daniel D., Karam, Jose A., Zemp, Logan, Master, Viraj A., Sexton, Wade J., Ghasemzadeh, Ali, Schmeusser, Benjamin N., Davaro, Facundo, Peak, Taylor, Patil, Dattatraya, Matin, Surena, Spiess, Philippe E., Abel, E. Jason
Publicado 2023

Predictive capacity of a miRNA panel in identifying teratoma in post‐chemotherapy consolidation surgeries

por Moore, Joseph A., Lehner, Michael J., Anfossi, Simone, Datar, Saumil, Tidwell, Rebecca S., Campbell, Matthew, Shah, Amishi Y., Ward, John F., Karam, Jose A., Wood, Christopher G., Pisters, Lois L., Calin, George A., Tu, Shi‐Ming
Publicado 2022